American Association of Oral and Maxillofacial Surgeons' position paper on medication-related osteonecrosis of the jaws—2022 update
SL Ruggiero, TB Dodson, T Aghaloo… - Journal of oral and …, 2022 - Elsevier
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …
the jaws (MRONJ)–formerly referred to as bisphosphonate-related osteonecrosis of the jaws …
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update
SL Ruggiero, TB Dodson, J Fantasia… - Journal of oral and …, 2014 - Elsevier
Strategies for management of patients with, or at risk for, medication-related osteonecrosis of
the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial …
the jaw (MRONJ) were set forth in the American Association of Oral and Maxillofacial …
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus
AA Khan, A Morrison, DA Hanley… - Journal of Bone and …, 2015 - Wiley Online Library
This work provides a systematic review of the literature from January 2003 to April 2014
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of …
pertaining to the incidence, pathophysiology, diagnosis, and treatment of osteonecrosis of …
Medication-related osteonecrosis of the jaw: MASCC/ISOO/ASCO clinical practice guideline
N Yarom, CL Shapiro, DE Peterson… - Journal of Clinical …, 2019 - ascopubs.org
PURPOSE To provide guidance regarding best practices in the prevention and
management of medication-related osteonecrosis of the jaw (MRONJ) in patients with …
management of medication-related osteonecrosis of the jaw (MRONJ) in patients with …
Treatment strategies and outcomes of bisphosphonate-related osteonecrosis of the jaw (BRONJ) with characterization of patients: a systematic review
The aim of this systematic review was to answer the question: What are the treatments
available for bisphosphonate-related osteonecrosis of the jaws (BRONJ) and their …
available for bisphosphonate-related osteonecrosis of the jaws (BRONJ) and their …
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the …
JW Hellstein, RA Adler, B Edwards… - The Journal of the …, 2011 - Elsevier
Background This narrative review of osteonecrosis of the jaw in patients with low bone mass
receiving treatment with antiresorptive agents is based on an appraisal of the literature by an …
receiving treatment with antiresorptive agents is based on an appraisal of the literature by an …
Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ
Osteonecrosis of the jaw (ONJ) has been associated with antiresorptive therapy in both
oncology and osteoporosis patients. This debilitating condition is very rare and advances in …
oncology and osteoporosis patients. This debilitating condition is very rare and advances in …
Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS
AD Anastasilakis, J Pepe, N Napoli… - The Journal of …, 2022 - academic.oup.com
Context Antiresorptive therapy significantly reduces fracture risk in patients with benign bone
disease and skeletal-related events (SREs) in patients with bone metastases (BM) …
disease and skeletal-related events (SREs) in patients with bone metastases (BM) …
Review and update on drugs related to the development of osteonecrosis of the jaw
A Eguia, L Bagan, F Cardona - Medicina oral, patologia oral y …, 2019 - pmc.ncbi.nlm.nih.gov
Background Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but serious
adverse effect of certain drugs, of which bisphosphonates are the most widely known. This …
adverse effect of certain drugs, of which bisphosphonates are the most widely known. This …
Medication-related osteonecrosis of the jaw: Clinical and practical guidelines
D Rosella, P Papi, R Giardino, E Cicalini… - … Society of Preventive …, 2016 - journals.lww.com
Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse drug reaction,
consisting of progressive bone destruction in the maxillofacial region of patients. ONJ can be …
consisting of progressive bone destruction in the maxillofacial region of patients. ONJ can be …